Persistence of circulating T-follicular helper cells after rituximab is associated with relapse of IgG4-related disease

Mancuso G.;Lanzillotta M.;Aiuti A.;Cicalese M. P.;Dagna L.;
2021-01-01

2021
Aged
Antirheumatic Agents
Female
Humans
Immunoglobulin G4-Related Disease
Male
Middle Aged
Prognosis
Recurrence
Rituximab
T Follicular Helper Cells
Treatment Outcome
Aged
Antirheumatic Agents
Female
Humans
Immunoglobulin G4-Related Disease
Male
Middle Aged
Prognosis
Recurrence
Rituximab
T Follicular Helper Cells
Treatment Outcome
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/126616
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 7
social impact